ROSGQ.US Rosetta Genomics Ltd

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Nov 17, 2026
0.0001 0.0002
Market cap
USD 592.00
P/E
-
P/B
0.01x
ROE
-794.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2017.

Is ROSGQ.US undervalued?

Graham number

The Graham number of Rosetta Genomics Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Rosetta Genomics Ltd fundamental analysis

No fundamental analysis for Rosetta Genomics Ltd yet.

Rosetta Genomics Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Rosetta Genomics Ltd

Rosetta Genomics Ltd. operates as a genomic diagnostics company worldwide. The company's microRNA technologies based diagnostic tests include RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer; mi-KIDNEY, a kidney tumor classification test for pathology samples; RosettaGX Reveal for the diagnosis of indeterminate thyroid fine-needle aspirate samples; and mi-LUNG diagnostic tests. It also provides UroVysion, a urine-based Fluorescence In S…

Full company profile